BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17118104)

  • 1. Brain natriuretic peptide is unchanged after 4 weeks of continuous positive airway pressure therapy.
    Pepperell J; Stradling J; Davies R
    J Sleep Res; 2006 Dec; 15(4):463-4. PubMed ID: 17118104
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained effect of continuous positive airway pressure on baroreflex sensitivity in congestive heart failure patients with obstructive sleep apnea.
    Ruttanaumpawan P; Gilman MP; Usui K; Floras JS; Bradley TD
    J Hypertens; 2008 Jun; 26(6):1163-8. PubMed ID: 18475154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous positive airway pressure in heart failure patients with obstructive sleep apnoea.
    Ferrier KA; Neill AM; O'Meeghan T; Richards M; Campbell AJ
    Intern Med J; 2008 Nov; 38(11):829-36. PubMed ID: 18284461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP is not elevated in patients with obstructive sleep apnoea.
    Hübner RH; El Mokhtari NE; Freitag S; Rausche T; Göder R; Tiroke A; Lins M; Simon R; Bewig B
    Respir Med; 2008 Jan; 102(1):134-42. PubMed ID: 17892929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?
    Maisel A
    J Am Coll Cardiol; 2009 Dec; 55(1):61-4. PubMed ID: 20117365
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of oral appliances and CPAP on the left ventricle and natriuretic peptides.
    Hoekema A; Voors AA; Wijkstra PJ; Stegenga B; van der Hoeven JH; Tol CG; de Bont LG
    Int J Cardiol; 2008 Aug; 128(2):232-9. PubMed ID: 17727981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
    Shelton RJ; Goode K; Cleland JG
    Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813
    [No Abstract]   [Full Text] [Related]  

  • 9. Natriuretic peptides in sleep apnea.
    Krieger J; Grunstein R
    Am J Cardiol; 2005 Mar; 95(5):708. PubMed ID: 15721134
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac resynchronization therapy and B-type natriuretic peptide in heart failure.
    Huang DJ
    Chin Med J (Engl); 2009 Mar; 122(6):608-9. PubMed ID: 19323919
    [No Abstract]   [Full Text] [Related]  

  • 11. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
    Daniels LB; Barrett-Connor E
    J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased morning brain natriuretic peptide levels in children with nocturnal enuresis and sleep-disordered breathing: a community-based study.
    Sans Capdevila O; Crabtree VM; Kheirandish-Gozal L; Gozal D
    Pediatrics; 2008 May; 121(5):e1208-14. PubMed ID: 18450864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial.
    Kohler M; Pepperell JC; Davies RJ; Stradling JR
    Respiration; 2009; 78(2):141-6. PubMed ID: 18984944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-guided treatment of heart failure: still waiting for a definitive answer.
    Troughton RW; Frampton CM; Nicholls MG
    J Am Coll Cardiol; 2010 Dec; 56(25):2101-4. PubMed ID: 21144970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic and inflammatory markers of sleep apnea-hypopnea syndrome and nocturnal hypoxemia: effects of treatment with nasal continuous positive airway pressure].
    Sánchez A; Schwartz AR; Sánchez PL; Fernández JL; Ramos J; Martín-Herrero F; González-Celador R; Ruano R; Bregón I; Martín-Luengo C; Gómez FP
    Arch Bronconeumol; 2008 Oct; 44(10):531-9. PubMed ID: 19006633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating central sleep apnea in heart failure: outcomes revisited.
    Olson LJ; Somers VK
    Circulation; 2007 Jun; 115(25):3140-2. PubMed ID: 17592088
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence to nasal positive airway pressure therapy among school-aged children and adolescents with obstructive sleep apnea syndrome.
    Uong EC; Epperson M; Bathon SA; Jeffe DB
    Pediatrics; 2007 Nov; 120(5):e1203-11. PubMed ID: 17923535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating sleep apnea in heart failure patients: promises but still no prizes.
    Somers VK; Gami AS; Olson LJ
    J Am Coll Cardiol; 2005 Jun; 45(12):2012-4. PubMed ID: 15963402
    [No Abstract]   [Full Text] [Related]  

  • 19. Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.
    Cleland JG; Squire I; Ng L
    J Am Coll Cardiol; 2008 Sep; 52(13):1104-5. PubMed ID: 18848145
    [No Abstract]   [Full Text] [Related]  

  • 20. Day-night variations of serum interleukin-6 in patients with severe obstructive sleep apnea syndrome before and after continuous positive airway pressure (CPAP).
    Burioka N; Miyata M; Fukuoka Y; Endo M; Shimizu E
    Chronobiol Int; 2008 Sep; 25(5):827-34. PubMed ID: 18780208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.